Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dose Escalation and Safety”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00036517
What this trial is testing

Safety Study of the Chemotherapy Modulator PHY906 in Patients With Advanced Colorectal Cancer

Who this might be right for
Colorectal NeoplasmsDiarrhea
PhytoCeutica 30
Early research (Phase 1)Study completedNCT07412080
What this trial is testing

EDP167 in Healthy Volunteers and Subjects With Mild Dyslipidemia

Who this might be right for
Healthy Adult Male and Female VolunteersMild Dyslipidemia
Eddingpharm (Zhuhai) Co., Ltd. 40
Early research (Phase 1)Study completedNCT01247168
What this trial is testing

An Open-Label, Dose-Escalation Study of AZD2461

Who this might be right for
Refractory Solid TumorsCancer Tumor
AstraZeneca 75
Testing effectiveness (Phase 2)Study completedNCT02600390
What this trial is testing

SANGUINATE™ in Sickle Cell Disease Associated Leg Ulcer

Who this might be right for
Leg Ulcer
Prolong Pharmaceuticals 10
Early research (Phase 1)Study completedNCT01308723
What this trial is testing

A Dose-Finding and Exploratory Study of RO5323441 in Combination With Sorafenib in Patients With Hepatocellular Carcinoma

Who this might be right for
Carcinoma, Hepatocellular
Hoffmann-La Roche 6
Early research (Phase 1)Study completedNCT01611623
What this trial is testing

Safety and Pharmacology Study of SNX-5422 in Subjects With Refractory Solid Tumor Malignancies

Who this might be right for
Cancer
Esanex Inc. 9
Early research (Phase 1)Study completedNCT02268760
What this trial is testing

Safety, Tolerance, and Pharmacokinetics of BILN 2061 ZW in Healthy Male Subjects, Combined With Preliminary Evaluation of Food Effect

Who this might be right for
Healthy
Boehringer Ingelheim 103
Early research (Phase 1)Study completedNCT02573259
What this trial is testing

A Dose Escalation Study Of PF-06801591 In Melanoma, Head And Neck Cancer (SCCHN), Ovarian, Sarcoma, Non-Small Cell Lung Cancer, Urothelial Carcinoma or Other Solid Tumors

Who this might be right for
Part 1MELANOMASCCHN+6 more
Pfizer 147
Early research (Phase 1)Study completedNCT00345189
What this trial is testing

Study of Oral CNF2024 (BIIB021) in Advanced Solid Tumors

Who this might be right for
TumorsLymphoma
Biogen 70
Testing effectiveness (Phase 2)Study completedNCT01002950
What this trial is testing

Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACU-4429 in Subjects With Geographic Atrophy

Who this might be right for
Dry Age-related Macular DegenerationGeographic Atrophy
Kubota Vision Inc. 72
Early research (Phase 1)Looking for participantsNCT06745297
What this trial is testing

A Study in Healthy Men to Test How Well Different Doses of BI 3776528 Are Tolerated

Who this might be right for
Healthy
Boehringer Ingelheim 172
Early research (Phase 1)Study completedNCT03302897
What this trial is testing

Phase 1 LEP-F1 + GLA-SE Vaccine Trial in Healthy Adult Volunteers

Who this might be right for
Leprosy
Access to Advanced Health Institute (AAHI) 24
Early research (Phase 1)Study completedNCT01080820
What this trial is testing

A Safety, Tolerability and Pharmacokinetic Study of a Single Dose of CMX157 in Healthy Volunteers

Who this might be right for
Healthy
Jazz Pharmaceuticals 36
Very early researchUnknownNCT05707325
What this trial is testing

Safety, Tolerability and Preliminary Efficacy of Engineered Red Blood Cell in Patients With Advanced Malignancies

Who this might be right for
CancerSolid TumorHematologic Malignancy
Westlake Therapeutics 30
Early research (Phase 1)Study completedNCT04555850
What this trial is testing

A Phase 1b Study of Thymosin Beta 4 in Healthy Volunteers

Who this might be right for
Healthy
Beijing Northland Biotech. Co., Ltd. 30
Testing effectiveness (Phase 2)Study completedNCT06056791
What this trial is testing

Study of INKmune in Patients With mCRPC (CaRe Prostate)

Who this might be right for
CancerMetastatic Castration-resistant Prostate CancermCRPC
Inmune Bio, Inc. 12
Early research (Phase 1)Study completedNCT01863108
What this trial is testing

Safety Study of a Dendritic Cell-based Cancer Vaccine in Melanoma

Who this might be right for
MelanomaTumor VaccinesEffects of Immunotherapy
University Hospital, Grenoble 9
Early research (Phase 1)Ended earlyNCT02952989
What this trial is testing

A Safety Study of SGN-2FF for Patients With Advanced Solid Tumors

Who this might be right for
Carcinoma, Non-Small-Cell LungCarcinoma, Renal CellBreast Neoplasms+5 more
Seagen Inc. 47
Testing effectiveness (Phase 2)Study completedNCT01684410
What this trial is testing

Safety and Tolerability Trial of Inhaled Alpha1-Proteinase Inhibitor (Human), Hydrophobic Chromatography Process (Alpha-1 HC) in Subjects With Cystic Fibrosis

Who this might be right for
Cystic Fibrosis
Grifols Therapeutics LLC 30
Early research (Phase 1)Study completedNCT00885989
What this trial is testing

Safety and Tolerability of the First IV Dosing of SLV338 in Healthy Volunteers

Who this might be right for
Healthy
Solvay Pharmaceuticals 42
Next Page